Global Epinephrine Autoinjector Market 2017-2021


#1027811

84pages

Technavio

$ 3500

In Stock

About epinephrine autoinjector
Epinephrine is among the first line of treatment drugs for anaphylactic conditions and is considered a life-saving drug during emergencies. Epinephrine autoinjectors have proved to be a life savior for people with severe allergies from as early as the 1980s. The global epinephrine autoinjector market has been witnessing continuous technological innovations and developments over the years, after the first FDA approval of EpiPen in 1987.

Technavios analysts forecast the global epinephrine autoinjector market to grow at a CAGR of 14.58% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global epinephrine autoinjector market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of various epinephrine autoinjectors to key end-users such as hospitals, clinics, and individuals.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Epinephrine Autoinjector Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
ALK-Abell
Impax Laboratories
Lincoln Medical
Mylan
Other prominent vendors
Adamis Pharmaceuticals
Antares Pharma
Emerade
Hospira
Kaleo Pharma
Teva Pharmaceutical Industries
Market driver
Increasing prevalence of allergies
For a full, detailed list, view our report

Market challenge
Product recalls and regulatory issues
For a full, detailed list, view our report

Market trend
Tentative product launches
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.




Table of Contents

PART 01: Executive summary

PART 02: Scope of the report


Market overview
Top-vendor offerings


PART 03: Market research methodology


Research methodology
Economic indicators


PART 04: Introduction


Key market highlights
Epinephrine autoinjector: Overview


PART 05: Market landscape


Market overview
Market size and forecast
Five forces analysis


PART 06: Market segmentation by dosage


Global epinephrine autoinjector market by 0.15gm dosage
Global epinephrine autoinjector market by 0.30gm dosage
Global epinephrine autoinjector market by 0.5gm dosage


PART 07: Market segmentation by age group

PART 08: Market segmentation by end-user


Hospitals and clinics
Individuals


PART 09: Geographical segmentation


Epinephrine autoinjector market in the Americas
Epinephrine autoinjector market in EMEA
Epinephrine autoinjector market in APAC


PART 10: Market drivers


Increasing prevalence of allergies
Technological advances
Marketing strategies


PART 11: Impact of drivers

PART 12: Market challenges


Product recalls and regulatory issues
Presence of substitutes
High cost


PART 13: Impact of drivers and challenges

PART 14: Market trends


Tentative product launches
Growing awareness about epinephrine autoinjectors
Patient assistance programs


PART 15: Vendor landscape


Competitive scenario
Key news
Geographical presence of key vendors


PART 16: Key vendor analysis


ALK-Abell
Impax Laboratories
Lincoln Medical
Mylan
Other prominent vendors


PART 17: Appendix


List of abbreviations


PART 18: Explore Technavio
List of Exhibits

Exhibit 01: Product offerings

Exhibit 02: Global epinephrine autoinjector market: Analysis

Exhibit 03: Key buying criteria for epinephrine autoinjectors

Exhibit 04: Buying criteria for epinephrine autoinjectors

Exhibit 05: Key factors influencing development of epinephrine autoinjectors

Exhibit 06: Allergy statistics

Exhibit 07: Market overview: Global epinephrine autoinjector market

Exhibit 08: Global epinephrine autoinjector market ($ millions)

Exhibit 09: Global epinephrine autoinjector market analysis: Developed and developing markets

Exhibit 10: Five forces analysis

Exhibit 11: Global epinephrine autoinjector market segmentation by dosage 2016

Exhibit 12: Global epinephrine autoinjector market segmentation by dosage 2020

Exhibit 13: Global epinephrine autoinjector market by 0.15gm dosage 2016-2021 ($ millions)

Exhibit 14: Global epinephrine autoinjector market by 0.30gm dosage 2016-2021 ($ millions)

Exhibit 15: Global epinephrine autoinjector market by 0.5gm dosage 2016-2021 ($ millions)

Exhibit 16: Global epinephrine autoinjector market segmentation by dosage 2016-2021 (%)

Exhibit 17: Global epinephrine autoinjector market segmentation by dosage 2016-2021 ($ millions)

Exhibit 18: Global epinephrine autoinjector market by age group 2016

Exhibit 19: Global epinephrine autoinjector market by end-user 2016

Exhibit 20: Global epinephrine autoinjector market segmentation by geography 2016

Exhibit 21: Global epinephrine autoinjector market segmentation by geography 2021

Exhibit 22: Epinephrine autoinjector market in the Americas 2016-2021 ($ millions)

Exhibit 23: Market overview: Americas

Exhibit 24: Epinephrine autoinjector market overview: US

Exhibit 25: Epinephrine autoinjector market in the US 2016-2021 ($ millions)

Exhibit 26: Market overview: EMEA

Exhibit 27: Epinephrine autoinjector market in EMEA 2016-2021 ($ millions)

Exhibit 28: Market overview: APAC

Exhibit 29: Epinephrine autoinjector market in APAC 2016-2021 ($ millions)

Exhibit 30: Global epinephrine autoinjector market segmentation by geography 2016-2021 ($ millions)

Exhibit 31: Global epinephrine autoinjector market segmentation by geography 2016-2021 (%)

Exhibit 32: Allergy statistics

Exhibit 33: Technological advances

Exhibit 34: Marketing strategies of Mylan

Exhibit 35: Impact of drivers

Exhibit 36: Product recalls

Exhibit 37: Alternatives of epinephrine autoinjectors in the market

Exhibit 38: Impact of drivers and challenges

Exhibit 39: Competitive structure of the global epinephrine autoinjector market

Exhibit 40: Market penetration of various epinephrine autoinjector manufacturers globally (2016)

Exhibit 41: Strategic success factors of companies in global epinephrine autoinjector market 2016

Exhibit 42: Share of vendors in global epinephrine autoinjector market 2016

Exhibit 43: Regional analysis of key vendors

Exhibit 44: Key highlights of ALK-Abell

Exhibit 45: ALK-Abell strength assessment

Exhibit 46: ALK-Abell strategy assessment

Exhibit 47: ALK-Abell opportunity assessment

Exhibit 48: Key highlights of Impax Laboratories

Exhibit 49: Impax Laboratories strength assessment

Exhibit 50: Impax Laboratories strategy assessment

Exhibit 51: Impax Laboratories opportunity assessment

Exhibit 52: Lincoln Medical strength assessment

Exhibit 53: Lincoln Medical strategy assessment

Exhibit 54: Lincoln Medical opportunity assessment

Exhibit 55: Key highlights of Mylan

Exhibit 56: Mylan strength assessment

Exhibit 57: Mylan strategy assessment

Exhibit 58: Mylan opportunity assessment